DLD Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
Other funds holding OSIR
DLD Asset Management's OSIR Position: Q2 2019 in Review
DLD Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 100,000 shares — an estimated $1.9M sold.
DLD Asset Management first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $1.9M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.
- DLD Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- DLD Asset Management sold 100,000 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.9M.
- DLD Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
- DLD Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.9M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.
Based on DLD Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.